171 related articles for article (PubMed ID: 12909310)
1. Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia.
Riksen NP; Rongen GA; Blom HJ; Russel FG; Boers GH; Smits P
Cardiovasc Res; 2003 Aug; 59(2):271-6. PubMed ID: 12909310
[TBL] [Abstract][Full Text] [Related]
2. Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemia.
Riksen NP; Rongen GA; Blom HJ; Boers GH; Smits P
Clin Chem Lab Med; 2005; 43(10):1001-6. PubMed ID: 16197288
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia.
Riksen NP; Rongen GA; Boers GH; Blom HJ; van den Broek PH; Smits P
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):109-14. PubMed ID: 15539618
[TBL] [Abstract][Full Text] [Related]
4. Adenosine-the missing link to understanding homocysteine pathogenicity or more smoke on the horizon?
Deussen A
Cardiovasc Res; 2003 Aug; 59(2):259-61. PubMed ID: 12909306
[No Abstract] [Full Text] [Related]
5. Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism.
Xiao Y; Su X; Huang W; Zhang J; Peng C; Huang H; Wu X; Huang H; Xia M; Ling W
Int J Biochem Cell Biol; 2015 Oct; 67():158-66. PubMed ID: 26117455
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
Paganelli F; Mottola G; Fromonot J; Marlinge M; Deharo P; Guieu R; Ruf J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567540
[TBL] [Abstract][Full Text] [Related]
7. Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine.
Fu W; Dudman NP; Perry MA; Young K; Wang XL
Biochem Biophys Res Commun; 2000 Apr; 271(1):47-53. PubMed ID: 10777679
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
9. Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC.
Castro R; Rivera I; Martins C; Struys EA; Jansen EE; Clode N; Graça LM; Blom HJ; Jakobs C; de Almeida IT
J Mol Med (Berl); 2005 Oct; 83(10):831-6. PubMed ID: 15976919
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine, iron and cardiovascular disease: a hypothesis.
Baggott JE; Tamura T
Nutrients; 2015 Feb; 7(2):1108-18. PubMed ID: 25668155
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine-induced endothelial cell adhesion is related to adenosine lowering and is not mediated by S-adenosylhomocysteine.
Cacciapuoti G; Manna C; Napoli D; Zappia V; Porcelli M
FEBS Lett; 2007 Oct; 581(24):4567-70. PubMed ID: 17850795
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia and cardiovascular disease in animal model.
Azad MAK; Huang P; Liu G; Ren W; Teklebrh T; Yan W; Zhou X; Yin Y
Amino Acids; 2018 Jan; 50(1):3-9. PubMed ID: 29018979
[TBL] [Abstract][Full Text] [Related]
13. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine, coagulation, platelet function, and thrombosis.
Coppola A; Davi G; De Stefano V; Mancini FP; Cerbone AM; Di Minno G
Semin Thromb Hemost; 2000; 26(3):243-54. PubMed ID: 11011842
[TBL] [Abstract][Full Text] [Related]
15. [Hyperhomocysteinemia and the disturbance of haemostasis--facts and mythes].
Malinowska J; Nowak P; Olas B
Pol Merkur Lekarski; 2009 Nov; 27(161):413-8. PubMed ID: 19999808
[TBL] [Abstract][Full Text] [Related]
16. Effects of homocysteine on vascular and tissue adenosine: a stake in homocysteine pathogenicity?
Deussen A; Pexa A; Loncar R; Stehr SN
Clin Chem Lab Med; 2005; 43(10):1007-10. PubMed ID: 16197289
[TBL] [Abstract][Full Text] [Related]
17. On the mechanism of homocysteine pathophysiology and pathogenesis: a unifying hypothesis.
Zhu BT
Histol Histopathol; 2002 Oct; 17(4):1283-91. PubMed ID: 12371153
[TBL] [Abstract][Full Text] [Related]
18. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D
Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912
[TBL] [Abstract][Full Text] [Related]
19. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
20. [Consequences of moderate hyperhomocysteinemia in internal medicine].
Zák A; Zeman M
Cas Lek Cesk; 2004; 143(6):367-74. PubMed ID: 15309862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
